Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Dawany, Noor ^a   Showe, Louise C ^a   Kossenkov, Andrew V ^a   Chang, Celia ^a   Ive, Prudence ^b   Conradie, Francesca ^b   Stevens, Wendy ^b   Sanne, Ian ^b   Azzoni, Livio ^a   Montaner, Luis J ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; TUBERCULOSTATIC AGENT; TRANSCRIPTOME;

ACCURACY; ADULT; ARTICLE; BACTERIUM DETECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATENT TUBERCULOSIS; MALE; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; TREATMENT DURATION; TREATMENT RESPONSE; TUBERCULOSIS; VALIDATION PROCESS; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MICROBIOLOGY; MONONUCLEAR CELL; SOUTH AFRICA; VIROLOGY;

ADULT; COINFECTION; FEMALE; GENE EXPRESSION PROFILING; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SUPPORT VECTOR MACHINE; TRANSCRIPTOME; TUBERCULOSIS;

EID: 84896135698     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089925     Document Type: Article

References (35)

1. (2011) Global tuberculosis control: WHO report 2011. Geneva, CH: WHO.
2. Dye C (2006) Global epidemiology of tuberculosis. Lancet 367: 938-940.
3. Tufariello JM, Chan J, Flynn JL (2003) Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 3: 578-590. (Pubitemid 37064537)
4. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163: 1009-1021. (Pubitemid 36548927)
5. Toossi Z, Funderburg NT, Sirdeshmuk S, Whalen CC, Nanteza MW, et al. (2013) Systemic Immune Activation and Microbial Translocation in Dual HIV/Tuberculosis-Infected Subjects. The Journal of infectious diseases 207: 1841-1849.
6. Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, et al. (2007) HIV infection and multidrug-resistant tuberculosis: the perfect storm. The Journal of infectious diseases 196 Suppl 1: S86-107.
7. McShane H (2005) Co-infection with HIV and TB: double trouble. Int J STD AIDS 16: 95-100; quiz 101.
8. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S (2006) Survival rate and risk factors of mortality among HIV/tuberculosis- coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr 43: 42-46. (Pubitemid 44306486)
9. Zhang Y (2007) Advances in the treatment of tuberculosis. Clin Pharmacol Ther 82: 595-600.
10. Suchindran S, Brouwer ES, Van Rie A (2009) Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PloS one 4: e5561.
11. Mehta PK, Raj A, Singh N, Khuller GK (2012) Diagnosis of extrapulmonary tuberculosis by PCR. FEMS Immunol Med Microbiol.
12. Fan L, Chen Z, Hao XH, Hu ZY, Xiao HP (2012) Interferon-gamma release assays for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. FEMS Immunol Med Microbiol 65: 456-466.
13. Metcalfe JZ, Everett CK, Steingart KR, Cattamanchi A, Huang L, et al. (2011) Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis 204 Suppl 4: S1120-1129.
14. Rangaka MX, Wilkinson KA, Glynn JR, Ling D, Menzies D, et al. (2012) Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 12: 45-55.
15. Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149: 177-184.
16. Shah M, Variava E, Holmes CB, Coppin A, Golub JE, et al. (2009) Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. J Acquir Immune Defic Syndr 52: 145-151.
17. Shah M, Ssengooba W, Armstrong D, LN, Hoe Y, et al. (2013) Comparative performance of rapid urinary lipoarabidomannan assay and Xpert MTB/RIF in HIV+ TB suspects: Uganda. 20th conference on Retroviruses and Opportunistic Infections. Atlanta, GA.
18. Perkins MD, Cunningham J (2007) Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. The Journal of infectious diseases 196 Suppl 1: S15-27. (Pubitemid 47206081)
19. Weyer K, Carai S, Nunn P (2011) Viewpoint TB diagnostics: what does the world really need? The Journal of infectious diseases 204 Suppl 4: S1196-1202.
20. Mikhailovich V, Gryadunov D, Kolchinsky A, Makarov AA, Zasedatelev A (2008) DNA microarrays in the clinic: infectious diseases. Bioessays 30: 673-682. (Pubitemid 351899654)
21. Lesho E, Forestiero FJ, Hirata MH, Hirata RD, Cecon L, et al. (2011) Transcriptional responses of host peripheral blood cells to tuberculosis infection. Tuberculosis (Edinb) 91: 390-399.
22. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
23. Jacobsen M, Repsilber D, Kleinsteuber K, Gutschmidt A, Schommer-Leitner S, et al. (2011) Suppressor of cytokine signaling-3 is affected in T-cells from tuberculosisTB patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 17: 1323-1331.
24. Lu C, Wu J, Wang H, Wang S, Diao N, et al. (2011) Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells. PLoS One 6: e24290.
25. Stern JN, Keskin DB, Romero V, Zuniga J, Encinales L, et al. (2009) Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report. Immunol Res 45: 1-12.
26. Bloom CI, Graham CM, Berry MP, Wilkinson KA, Oni T, et al. (2012) Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy. PloS one 7: e46191.
27. Conradie F, Foulkes AS, Ive P, Yin X, Roussos K, et al. (2011) Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection. J Acquir Immune Defic Syndr 58: 309-318.
28. Guyon I, Weston J, Barnhill S, Vapnik V (2002) Gene selection for cancer classification using support vector machines. Machine Learning 46: 389-422. (Pubitemid 34129977)
29. Kossenkov AV, Vachani A, Chang C, Nichols C, Billouin S, et al. (2011) Resection of non-small cell lung cancers reverses tumor-induced gene expression changes in the peripheral immune system. Clin Cancer Res 17: 5867-5877.
30. Showe MK, Vachani A, Kossenkov AV, Yousef M, Nichols C, et al. (2009) Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res 69: 9202-9210.
31. Nebozhyn M, Loboda A, Kari L, Rook AH, Vonderheid EC, et al. (2006) Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy. Blood 107: 3189-3196.
32. Paik S, Shak S, Tang G, Kim C, Baker J, et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. The New England journal of medicine 351: 2817-2826. (Pubitemid 40051905)
33. Lawn SD, Kerkhoff AD, Vogt M, Wood R (2012) Diagnostic accuracy of a lowcost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. The Lancet infectious diseases 12: 201-209.
34. Shah M, Variava E, Holmes CB, Coppin A, Golub JE, et al. (2009) Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. Journal of acquired immune deficiency syndromes 52: 145-151.
35. Armand S, Vanhuls P, Delcroix G, Courcol R, Lemaitre N (2011) Comparison of the Xpert MTB/RIF test with an IS6110-TaqMan real-time PCR assay for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. Journal of clinical microbiology 49: 1772-1776.